Healthcare professionals who use the healthcare products mentioned in 18° to 20° of Article L. 5311-1 shall report without delay to the Agence nationale de sécurité du médicament et des produits de santé any incident involving these products likely to have adverse effects on people’s health. The procedures for applying this article are determined by decree in the Conseil d’Etat.